Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Nvidia! Turnaround for Nel, Saturn Oil & Gas, Lufthansa, TUI?

It looks like a peak is forming in artificial intelligence. The most prominent share here is Nvidia (NDAQ:NVDA) . With a spectacular rally, the value has surged by more than 100 per cent in just six months. However, the share price is now stuttering, and there have been ...
André Will-Laudien | April 18, 2024 |

BASF and Cardiol Therapeutics recommended buys; TUI rides momentum

BASF (OTCQX:BASFY) shares have gained over 30% within six months. But is the rally in BASF shares slowly running out of steam? The fact that the stock did not rise sharply yesterday despite a significant price target increase suggests this is the case. Many experts see ...
Fabian Lorenz | April 10, 2024 |

Buzz on the Bullboards: Highlights from Bay Street to Wall Street

As investors reflect on the past week’s market movements, it’s clear that some notable shifts have taken place in the Canadian and U.S. stock markets. On Bay Street, the Toronto Stock Exchange witnessed intriguing developments, while Wall S...
Jonathon Brown | April 4, 2024 |

Buzz on the Bullboards: Pulling gains out of volatile territory

As the global economy navigates uncertainties, investors have been watching the performance of key stock markets for insights into prevailing sentiment and economic health. Over the past week, the TSX and the trio of indices on Wall Street – the Dow Jones Industrial A...
Jonathon Brown | March 28, 2024 |

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...
Knox Henderson | March 20, 2024 |

Canada’s top edible cannabis producer eyes further growth

The following is a transcription of the above video, and The Market Online has edited it for clarity . Edible cannabis producer, Indiva Ltd. (TSXV:NDVA) , recently announced a LIFE private placement, open to all retail investors, and intends to raise a minimum of $...
Ryan Dhillon | March 20, 2024 |

Leading logistics company emphasizes risk mitigation

Our next company is Mullen Group Ltd. (TSX:MTL) , one of North America’s largest logistics providers, housing a network of independently operated businesses. We spoke with Randy Mercer, Director of Risk Management, who detailed the compa...
Brieanna McCutcheon | March 8, 2024 |

Buzz on the Bullboards: Upbeat U.S. earnings good news for all?

Do rising tides truly lift all ships? We are in the midst of a strong earnings season and U.S. markets have reacted in kind. Strong earnings growth pushed Wall Street indices towards fresh record highs this past week. While activity moved lower earlier on, the belief ...
Jonathon Brown | February 8, 2024 |

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma Corp. (TSX-V:NGEN; OTCQX:NGENF) is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast interview about the company’s ongoing Phase 1b/2...
Knox Henderson | February 1, 2024 |

Buzz on the Bullboards: Good stocks with bad publicity

It was hedge fund legend Ray Dalio who said: “He who lives by the crystal ball will eat shattered glass.” Many stock markets may have seen a higher start to the year so far, but there is far from a universal sentiment across the sectors, with s...
Jonathon Brown | January 25, 2024 |
1 2 3 4 5 6 7 8 9 10 ...